Adakveo, a drug based on the discoveries of OMRF VP of Research Rodger McEver, is relieving pain for Danielle Jamison and others with sickle cell around the world.
Dr. Rod McEver was elected as an AAAS Fellow for his research in cardiovascular biology and hematology.
An Oklahoma teenager battling cancer was given just weeks to live – that was more than 50 years ago.
The application deadline is Feb. 1.
Adakveo significantly reduces pain crises in sickle cell patients.
Scientists at OMRF have made new findings that could pave the way for the first drug to treat aortic stenosis.